---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-086470"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T11:46:23.756912+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents Q2 revenue $9.4M (+11% YoY); STAR-T trial enrollment complete

## Summary
- Product sales rose 10% to $8.1M; product gross margins improved 700 bps to 74%.
- STAR-T pivotal trial for DrugSorb-ATR completed enrollment ahead of schedule; DSMB recommended completion.
- Quarterly cash burn reduced to ~$4.5M in H1 2023 from ~$11M in H1 2022.
- Appointed Alexander D'Amico as CFO effective August 7, 2023; Michael Bator named Chairman.
- Cash and restricted cash totaled $14.8M as of June 30, 2023.

## SEC filing metadata
- accession: 0001104659-23-086470
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465923086470/0001104659-23-086470-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465923086470/tm2322460d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-086470
- JSON: https://secwatch.observer/filing/0001104659-23-086470.json
- Plain text: https://secwatch.observer/filing/0001104659-23-086470.txt

## Key facts
- Earnings Releases
  Cytosorbents Corp reported the quarter ended June 30, 2023 results: revenue $9.4 million.
  - Period: the quarter ended June 30, 2023
  - Revenue: $9.4 million
  - Result: reported results
  source text: Q2 2023 Total Revenue was $9.4 million, an 11% increase from $8.5 million in Q2 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923086470/0001104659-23-086470-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.